Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,808 | 381 | 63.9% |
| Gift | $4,006 | 2 | 29.1% |
| Entertainment | $946.98 | 25 | 6.9% |
| Education | $16.74 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Tosoh Bioscience, Inc. | $4,006 | 2 | $0 (2019) |
| Romark Laboratories, LC | $2,378 | 114 | $0 (2020) |
| ABBVIE INC. | $2,045 | 95 | $0 (2024) |
| Boston Scientific Corporation | $658.72 | 14 | $0 (2023) |
| PFIZER INC. | $490.06 | 19 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $430.58 | 23 | $0 (2022) |
| Takeda Pharmaceuticals U.S.A., Inc. | $329.34 | 15 | $0 (2020) |
| INTERCEPT PHARMACEUTICALS, INC. | $324.48 | 7 | $0 (2023) |
| Gilead Sciences, Inc. | $294.89 | 11 | $0 (2024) |
| Merck Sharp & Dohme LLC | $290.78 | 12 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $961.31 | 23 | ABBVIE INC. ($454.51) |
| 2023 | $835.90 | 26 | AbbVie Inc. ($331.45) |
| 2022 | $618.41 | 30 | ABBVIE INC. ($205.47) |
| 2021 | $905.54 | 36 | BOSTON SCIENTIFIC CORPORATION ($286.10) |
| 2020 | $469.22 | 14 | Takeda Pharmaceuticals U.S.A., Inc. ($142.99) |
| 2019 | $6,261 | 92 | Tosoh Bioscience, Inc. ($4,006) |
| 2018 | $1,881 | 98 | Romark Laboratories, LC ($573.37) |
| 2017 | $1,846 | 90 | Romark Laboratories, LC ($889.74) |
All Payment Transactions
409 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.64 | General |
| Category: Immunology | ||||||
| 11/13/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/07/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $124.90 | General |
| Category: IMMUNOLOGY | ||||||
| 10/17/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $33.41 | General |
| Category: Rare Disease | ||||||
| 10/07/2024 | CapsoVision, Inc. | CapsoCam Plus (Device) | Food and Beverage | Cash or cash equivalent | $158.25 | General |
| Category: Gastroenterology | ||||||
| 10/03/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $21.05 | General |
| 09/11/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: VIROLOGY | ||||||
| 08/01/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $28.79 | General |
| Category: Immunology | ||||||
| 07/18/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: IMMUNOLOGY | ||||||
| 06/20/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $25.99 | General |
| Category: Immunology | ||||||
| 06/12/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $36.22 | General |
| Category: THERAPY FOR CSID | ||||||
| 06/06/2024 | E.R. Squibb & Sons, L.L.C. | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $122.11 | General |
| Category: Neuroscience | ||||||
| 05/14/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $16.65 | General |
| Category: ENDOCRINOLOGY | ||||||
| 05/13/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $58.31 | General |
| 05/07/2024 | Ferring Pharmaceuticals Inc. | REBYOTA (Biological) | Food and Beverage | In-kind items and services | $20.94 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/02/2024 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $19.34 | General |
| 03/08/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: ENDOCRINOLOGY | ||||||
| 03/07/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $88.04 | General |
| Category: ENDOCRINOLOGY | ||||||
| 03/07/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $27.55 | General |
| Category: IMMUNOLOGY | ||||||
| 02/28/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: IMMUNOLOGY | ||||||
| 02/08/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $24.42 | General |
| Category: VIROLOGY | ||||||
| 01/31/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $29.87 | General |
| Category: IMMUNOLOGY | ||||||
| 01/18/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $22.25 | General |
| Category: IMMUNOLOGY | ||||||
| 12/20/2023 | AbbVie Inc. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $28.74 | General |
| Category: IMMUNOLOGY | ||||||
| 12/01/2023 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $27.39 | General |
| Category: General - Biliary Devices_ENDO | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 944 | 1,061 | $418,764 | $93,763 |
| 2022 | 15 | 1,008 | 1,165 | $445,301 | $100,396 |
| 2021 | 18 | 971 | 1,102 | $455,708 | $99,541 |
| 2020 | 15 | 651 | 715 | $296,077 | $63,734 |
All Medicare Procedures & Services
65 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 117 | 117 | $51,256 | $15,210 | 29.7% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 71 | 71 | $77,704 | $9,566 | 12.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 83 | 86 | $29,696 | $9,518 | 32.1% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 88 | 88 | $83,556 | $9,400 | 11.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 84 | 89 | $29,932 | $8,801 | 29.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 108 | 116 | $27,516 | $8,066 | 29.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 58 | 99 | $18,367 | $6,573 | 35.8% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 87 | 141 | $14,715 | $5,965 | 40.5% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 25 | 25 | $28,426 | $5,748 | 20.2% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 23 | 23 | $21,229 | $4,421 | 20.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 47 | 47 | $13,732 | $3,950 | 28.8% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 12 | 12 | $11,088 | $2,317 | 20.9% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 40 | 41 | $5,248 | $2,061 | 39.3% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 40 | 40 | $2,400 | $1,025 | 42.7% |
| 91065 | Measurement of hydrogen in breath to test for stomach and bowel symptoms | Office | 2023 | 13 | 13 | $3,211 | $722.42 | 22.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 37 | 42 | $479.00 | $335.44 | 70.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 11 | 11 | $209.00 | $83.71 | 40.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 107 | 107 | $46,274 | $13,872 | 30.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 121 | 225 | $40,725 | $13,567 | 33.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 110 | 134 | $44,890 | $12,833 | 28.6% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 74 | 74 | $83,408 | $10,234 | 12.3% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 83 | 83 | $72,993 | $9,571 | 13.1% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 34 | 35 | $40,948 | $7,964 | 19.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 74 | 79 | $18,644 | $5,925 | 31.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 63 | 63 | $18,270 | $5,434 | 29.7% |
About Dr. Salvatore Buffa, MD
Dr. Salvatore Buffa, MD is a Gastroenterology healthcare provider based in Poughkeepsie, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/09/2005. The National Provider Identifier (NPI) number assigned to this provider is 1346244027.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Salvatore Buffa, MD has received a total of $13,778 in payments from pharmaceutical and medical device companies, with $961.31 received in 2024. These payments were reported across 409 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($8,808).
As a Medicare-enrolled provider, Buffa has provided services to 3,574 Medicare beneficiaries, totaling 4,043 services with total Medicare billing of $357,434. Data is available for 4 years (2020–2023), covering 65 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Poughkeepsie, NY
- Active Since 06/09/2005
- Last Updated 04/24/2015
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1346244027
Products in Payments
- 25-OH Vitamin D ST AIA-Pack (Medical Supply) $2,003
- TES, ST AIA-PACK (Medical Supply) $2,003
- Alinia Tablets 500mg 30 count bottle (Drug) $1,463
- Alinia (Drug) $831.91
- RINVOQ (Biological) $399.52
- Humira (Biological) $344.91
- OCALIVA (Drug) $324.48
- XELJANZ (Drug) $319.57
- EXALT (Device) $271.99
- DIFICID (Drug) $253.16
- XIFAXAN (Drug) $228.18
- LINZESS (Drug) $227.54
- MAVYRET (Drug) $221.96
- SKYRIZI (Biological) $197.47
- Entyvio (Biological) $187.79
- Mavyret (Drug) $185.46
- INFLECTRA (Biological) $170.49
- EXALT Model D (Device) $167.30
- CapsoCam Plus (Device) $158.25
- HUMIRA (Biological) $141.59
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Poughkeepsie
Anthony Starpoli, M.d, M.D
Gastroenterology — Payments: $47,720
Dr. Robert Dean, Md, MD
Gastroenterology — Payments: $37,658
Dr. Peter Varunok, Md, MD
Gastroenterology — Payments: $35,234
Ravi Hotchandani, Md, MD
Gastroenterology — Payments: $28,261
Dr. Farah Toyserkani, Md, MD
Gastroenterology — Payments: $10,977
Tamer Sargios, Md, MD
Gastroenterology — Payments: $10,349